Cerevel Therapeutics
Show contact
Links
Previous companies
John Renger
Chief Scientific Officer
Sean Curley
Principal Scientist
Kristen Larrabee
Executive Assistant To Chief Science Officer
Claude Barberis
Vice President, Medicinal Chemistry
David J. Stone
Vice President, Genetics And Target Identification
+ 27 more
February 1, 2024 - present
June, 2022
View in org chart
